This is to inform you that the shareholders of the Company at 33rd AGM of Garodia Chemicals Limited (''the Company'') which was held on Tuesday, September 30, 2025 at 04:00 P.M. (IST) through ....
Awaiting price reaction for this filing.
Garodia Chemicals held its 33rd Annual General Meeting on September 30, 2025, conducted via video conferencing from 4:00 PM to 4:30 PM. Shareholders approved the appointment of M/s. S. V. Kulkarni and Associates as Secretarial Auditors for a 5-year term covering FY 2025-26 to FY 2029-30. Five director appointments were also approved: Mrs. Bhagyashri Nilesh Devrale as Non-Executive Non-Independent Director, Mr. Ravindra Subhash Salunkhe as Managing Director, and Mr. Vikram Ravindra Sabnis, Mr. Suraj Kodak, and Mrs. Megha Brahmankar as Independent Directors, each for a 5-year term. All director appointments came into effect on September 30, 2025.
This is a routine governance update with multiple board appointments, including the formal elevation of Mr. Ravindra Salunkhe to Managing Director. Stock price impact is likely minimal as these are standard AGM-approved governance changes, though investors may note the strengthened board with three new independent directors.